The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression
Authors:
Open Access
- 21 December 2020
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 48 (3) , 422-434
Abstract
Nicotinamide phosphoribosyltransferase (NAMPT) is a rate‐limiting enzyme for nicotinamide adenine dinucleotide (NAD) synthesis and is involved in cancer cell proliferation through regulation of energy production pathways. Therefore, NAMPT inhibitors are promising drugs for cancer therapy by limiting energy supply of tumours. Herein, we demonstrated that the NAMPT inhibitor FK866 ((E)‐N‐(4‐(1‐Benzoylpiperidin‐4‐yl)butyl)‐3‐(pyridin‐3‐yl)acrylamide) dose‐dependently inhibited growth and cell motility of DU‐145 prostate tumour spheroids and decreased the intracellular ATP concentration. The apoptosis marker cleaved caspase‐3 remained unchanged, but the autophagy marker microtubule‐associated protein 1A/1B‐light chain 3 (LC3) was upregulated. Growth inhibition was reversed upon co‐administration of NAD to the cell culture medium. FK866 decreased calcein as well as pheophorbide A efflux from tumour spheroids and increased doxorubicin toxicity, indicating interference with function of drug efflux transporters. DU‐145 multicellular tumour spheroids expressed the stem cell associated markers CD133, CD44, Oct4, Nanog, Sox2, and drug transporters ABCB1, ABCG2, and ABCC1 which are associated with stem cell properties in cancer cells. The ABCB1 inhibitor zosuquidar, the ABCG2 inhibitor Ko143, and the ABCC1 inhibitor MK571 increased calcein retention. Neither protein expression of stem cell markers, nor drug transporters was significantly changed upon FK866 treatment. In conclusion, our data suggest that FK866 inhibits prostate cancer cell proliferation by interference with the energy metabolism, and function of drug efflux transporters.Keywords
This publication has 44 references indexed in Scilit:
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breastBMC Cancer, 2012
- Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like PropertiesPLOS ONE, 2011
- NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress responseOncogene, 2010
- A Preclinical Study on the Rescue of Normal Tissue by Nicotinic Acid in High-Dose Treatment with APO866, a Specific Nicotinamide Phosphoribosyltransferase InhibitorMolecular Cancer Therapeutics, 2010
- Glycolytic pyruvate regulates P‐Glycoprotein expression in multicellular tumor spheroids via modulation of the intracellular redox stateJournal of Cellular Biochemistry, 2009
- Function of Sirtuins in Biological TissuesThe Anatomical Record, 2009
- Pheophorbide a Is a Specific Probe for ABCG2 Function and InhibitionCancer Research, 2004
- Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroidsInternational Journal of Cancer, 1998
- Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assayAnti-Cancer Drugs, 1996